DoJ extends Biomet DPA
The US Department of Justice (DoJ) extended a foreign bribery deferred prosecution agreement with pharmaceuticals company Biomet for a year in March 2015, the company announced in a US Securities and Exchange Commission filing.
To read more
Subscribe to Global Investigations Review
Subscribe and start reading now
Global Investigations Review (GIR) is the hub for global coverage of corporate investigations and their aftermath. Keep up to date with significant developments in the corporate investigations world.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10